Table 1.
Baseline characteristics in different clinical groups of COVID-19 disease.
|
Characteristics |
Groups (N = 213) |
|||
|---|---|---|---|---|
| Home-discharge (n = 123) | Hospitalized (n = 58) | ICU (n = 32) | P | |
| Demographic | ||||
| Age | 48.67 ± 13.49 | 59.27 ± 16.16 | 58.03 ± 15.88 | 0.478 |
| Gender (Male) | 66(53.7%) | 24(41.4%) | 23(71.9%) | 0.021a |
| Pre-existing conditions | ||||
| Pulmonary | 13(10.56%) | 7(12.06%) | 4(12.5%) | 0.126 |
| Non-pulmonary | 38(30.89%) | 16(27.58%) | 14(43.75%) | 0.006a |
| Clinical | ||||
| Temperature (Co) | 36.28 ± 0.61 | 36.82 ± 0.55 | 37.02 ± 0.61 | <0.001a |
| SpO2 | 95.15 ± 3.07 | 90.64 ± 6.55 | 86.78 ± 8.69 | <0.001a |
| Dyspnea | 76(61.8%) | 45(77.6%) | 32(100%) | <0.001a |
| Laboratory | ||||
| ESR (mm/h) | 23.81 ± 19.42 | 61.83 ± 24.16 | 68.50 ± 25.74 | <0.001a |
| WBC (103/μL) | 5.80 ± 1.09 | 8.01 ± 4.06 | 10.02 ± 4.04 | < 0.001a |
| CRP (+) | 2.11 ± 1.28 | 2.09 ± 1.30 | 3.53 ± 0.90 | 0.175 |
| Lymphocytes (%) | 28.64 ± 12.28 | 20.08 ± 12.72 | 11.22 ± 6.27 | <0.001a |
| Final survival status | ||||
| Recovered | 123(100%) | 57(98.27%) | 9(28.12%) | <0.001a |
| Deceased | 0(0%) | 1(1.72%) | 23(71.87%) | |
- Abbreviation: ICU (Intensive care unit admitted), SpO2 (Peripheral oxygen saturation), ESR (Erythrocyte sedimentation rate), WBC (White blood cells), CRP (C-Reactive protein).
- (Mean ± SD or number, percent) were used.
- One-Way ANOVA and Chi-square tests were used.
a
Statistically significant (P value < 0.05).